4//SEC Filing
Olivier Thomas 4
Accession 0001213900-22-018094
CIK 0001662382other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 1:03 PM ET
Size
6.2 KB
Accession
0001213900-22-018094
Insider Transaction Report
Form 4
Olivier Thomas
Director
Transactions
- Award
Options to Purchase Shares of Common Stock
2022-02-03+362,069→ 362,069 totalExercise: $0.29Exp: 2031-12-11→ Common Stock (362,069 underlying)
Footnotes (1)
- [F1]The options were initially issued to Mr. Olivier pursuant to a stock option agreement, dated December 10, 2021, whereby Mr. Olivier was issued 61,140 options to purchase shares of common stock of the Issuer with an exercise price of $0.21. On February 3, 2022, the Issuer and Mr. Olivier entered into an amended stock option agreement (the "Amendment") whereby (i) the number of options issued to Mr. Olivier was amended to 362,069, and (ii) the exercise price was amended to $0.29. Pursuant to the Amendment, the options shall vest and become exercisable pursuant to the following schedule: 46,623 options vested and became exercisable on December 31, 2021, 89,277 options vested and became exercisable on March 31, 2022; 90,269 options shall become exercisable on June 30,2022, 91,261 options shall become exercisable on September 30,2022; and 44,639 options shall become exercisable on December 31, 2022.
Documents
Issuer
BRAIN SCIENTIFIC INC.
CIK 0001662382
Entity typeother
Related Parties
1- filerCIK 0001847422
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 1:03 PM ET
- Size
- 6.2 KB